Table of Content

1. Executive Summary
   1.1. Global Bispecific Antibodies Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations

2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Value Chain Analysis
   3.3. Key Deals and Mergers
   3.4. PESTLE Analysis
   3.5. Porter’s Five Force Analysis

4. Global Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Global Bispecific Antibodies Market Outlook: Indication
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
           4.3.3.1. Cancer
           4.3.3.2. Inflammatory & Autoimmune Disorder
           4.3.3.3. Others
   4.4. Market Attractiveness Analysis: Indication
   4.5. Global Bispecific Antibodies Market Outlook: End User
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
           4.5.3.1. Pharmaceutical companies
           4.5.3.2. Biotechnology companies
           4.5.3.3. Research institutions
           4.5.3.4. Hospitals and clinics
   4.6. Market Attractiveness Analysis: End User

5. Global Bispecific Antibodies Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region

6. North America Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Indication
       6.2.3. By End User
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       6.4.1. Cancer
       6.4.2. Inflammatory & Autoimmune Disorder
       6.4.3. Others
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       6.5.1. Pharmaceutical companies
       6.5.2. Biotechnology companies
       6.5.3. Research institutions
       6.5.4. Hospitals and clinics
   6.6. Market Attractiveness Analysis

7. Europe Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Indication
       7.2.3. By End User
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       7.4.1. Cancer
       7.4.2. Inflammatory & Autoimmune Disorder
       7.4.3. Others
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       7.5.1. Pharmaceutical companies
       7.5.2. Biotechnology companies
       7.5.3. Research institutions
       7.5.4. Hospitals and clinics
   7.6. Market Attractiveness Analysis

8. East Asia Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Indication
       8.2.3. By End User
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       8.4.1. Cancer
       8.4.2. Inflammatory & Autoimmune Disorder
       8.4.3. Others
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       8.5.1. Pharmaceutical companies
       8.5.2. Biotechnology companies
       8.5.3. Research institutions
       8.5.4. Hospitals and clinics
   8.6. Market Attractiveness Analysis

9. South Asia & Oceania Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Indication
       9.2.3. By End User
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       9.4.1. Cancer
       9.4.2. Inflammatory & Autoimmune Disorder
       9.4.3. Others
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       9.5.1. Pharmaceutical companies
       9.5.2. Biotechnology companies
       9.5.3. Research institutions
       9.5.4. Hospitals and clinics
   9.6. Market Attractiveness Analysis

10. Latin America Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Indication
       10.2.3. By End User
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       10.4.1. Cancer
       10.4.2. Inflammatory & Autoimmune Disorder
       10.4.3. Others
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       10.5.1. Pharmaceutical companies
       10.5.2. Biotechnology companies
       10.5.3. Research institutions
       10.5.4. Hospitals and clinics
   10.6. Market Attractiveness Analysis

11. Middle East & Africa Bispecific Antibodies Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Indication
       11.2.3. By End User
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       11.4.1. Cancer
       11.4.2. Inflammatory & Autoimmune Disorder
       11.4.3. Others
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
       11.5.1. Pharmaceutical companies
       11.5.2. Biotechnology companies
       11.5.3. Research institutions
       11.5.4. Hospitals and clinics
   11.6. Market Attractiveness Analysis

12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Amgen
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. F. Hoffmann-La Roche Ltd
       12.3.3. Genentech
       12.3.4. Akeso, Inc.
       12.3.5. Janssen
       12.3.6. Taisho Pharmaceutical
       12.3.7. Immunocore
       12.3.8. MacroGenics, Inc
       12.3.9. CELGENE CORPORATION
       12.3.10. Sanofi
       12.3.11. AstraZeneca

13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations